Home / Inspections / 859943

FDA Inspection 859943 — Medtronic Neuromodulation

Medtronic Neuromodulation — FEI 2182207

The FDA completed an inspection of Medtronic Neuromodulation on December 19, 2013 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2013
Fiscal Year
2014
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Minneapolis, MN (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1206222 (VAI Fri May 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1187313 (VAI Thu Nov 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1153966 (NAI Thu Sep 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108789 (VAI Thu Oct 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102180 (NAI Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources